Inhibition of the JNK pathway by genetic or pharmacologic approaches has also been demonstrated to be effective at preventing and suppressing glomerulosclerosis and tubulointerstitial fibrosis [51]. This evidence concerns the gene MAPK8 and glomerulosclerosis.